News
SRRK ▼ -0.5% - Scholar Rock Holding Corporation
SRRK ▼ -0.5% - Scholar Rock Holding Corporation
$SRRK Scholar Rock Resubmits Apitegromab Marketing Authorisation Application (MAA) to European Medicines Agency (EMA) for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)
08-OCT-2026 08:03 AM ET
Share this post
More filings for $SRRK
SRRK ▼ -0.5% - Scholar Rock Holding CorporationOct 8, 2026SRRK ▼ -0.6% - Scholar Rock Holding CorporationSep 11, 2026SRRK ▼ -0.6% - Scholar Rock Holding CorporationSep 11, 2026SRRK ▼ -0.6% - Scholar Rock Holding CorporationSep 11, 2026SRRK ▲ +1.3% - Scholar Rock Holding CorporationSep 2, 2026SRRK ▲ +2.0% - Scholar Rock Holding CorporationSep 2, 2026
View full $SRRK filing history →💬 Comments
Loading comments…
Leave a comment